Gamma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone
Open accessAbstract
Gamma-hydroxybutyrate (GHB) is a GHB-/GABAB-receptor agonist. Reports from GHB abusers indicate euphoric, prosocial, and empathogenic effects of the drug. We measured the effects of GHB on mood, prosocial behavior, social and non-social cognition and assessed potential underlying neuroendocrine mechanisms. GHB (20mg/kg) was tested in 16 healthy males, using a randomized, placebo-controlled, cross-over design. Subjective effects on mood were assessed by visual-analogue-scales and the GHB-Specific-Questionnaire. Prosocial behavior was examined by the Charity Donation Task, the Social Value Orientation test, and the Reciprocity Task. Reaction time, memory, empathy, and theory-of-mind were also tested. Blood plasma levels of GHB, oxytocin, testosterone, progesterone, dehydroepiandrosterone (DHEA), cortisol, aldosterone, and adrenocorticotropic-hormone (ACTH) were determined. GHB showed stimulating and sedating effects, and elicited euphoria, disinhibition, and enhanced vitality. In participants with low prosociality, the drug increased donations and prosocial money distributions. In contrast, social cognitive abilities such as emotion recognition, empathy, and theory-of-mind, and basal cognitive functions were not affected. GHB increased plasma progesterone, while oxytocin and testosterone, cortisol, aldosterone, DHEA, and ACTH levels remained unaffected. GHB has mood-enhancing and prosocial effects without affecting social hormones such as oxytocin and testosterone. These data suggest a potential involvement of GHB-/GABAB-receptors and progesterone in mood and prosocial behavior.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Performance on the MASC after administration of GHB at 20 mg/kg did not reveal significant results.
“Performance on the MASC has been studied after the administration of GHB (20 mg/kg), but did not reveal significant results (41).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [41]
GHB at 20 mg/kg has been reported to increase the tendency to talk.
“GHB (20 mg/kg) has been reported to increase the tendency to talk (41).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [41]
GHB at 20 mg/kg was not shown to affect emotional empathy.
“In contrast to MDMA and LSD, GHB (20 mg/kg) was not shown to affect emotional empathy (41).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [41]
No effect was found for reciprocity during a Trust Game after GHB administration.
“No effect was found for reciprocity during a Trust Game after GHB administration (41).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [41]
After GHB at 20 mg/kg, participants showed more altruistic behavior on the Social Value Orientation Test and a Charity Donation Task, but only after participants who scored high at baseline were excluded from the analysis.
“After GHB (20 mg/kg) administration, participants also showed more altruistic behavior on the SVO and a Charity Donation Task, but only after participants who scored high at baseline were excluded from the analysis (41).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [41]
GHB induced prosocial behavior specifically in individuals with low progesterone levels.
“This indicates that GHB induced prosocial behavior specifically in individuals with low progesterone levels (41).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [41]
No correlations were found between GHB-induced neuroendocrine effects and social behavior, but low progesterone levels at baseline were predictive of altruistic behavior on the SVO and a Charity Donation Task after GHB administration.
“No correlations were found between GHB-induced neuroendocrine effects and social behavior, but low progesterone levels at baseline were predictive of altruistic behavior on the SVO and a Charity Donation Task after GHB administration.”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [41]
GHB increases plasma progesterone, but not oxytocin or testosterone levels.
“Furthermore, GHB has been shown to increase plasma progesterone, but not oxytocin or testosterone levels (41).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [41]
Cites
Measuring Social Value OrientationPreprint
Murphy, R. O., Ackermann, K., & Handgraaf, M. (2011) · Social Science Research Network · doi:10.2139/ssrn.1804189 · Cited by 1,099 · see citing works
Dziobek, I., Rogers, K., Fleck, S., Bahnemann, M., Heekeren, H. R., Wolf, O. T., & Convit, A. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-007-0486-x · Cited by 951 · see citing works
Measuring Social Value Orientation
Murphy, R. O., Ackermann, K. A., & Handgraaf, M. J. J. (2011) · Judgment and Decision Making · doi:10.1017/s1930297500004204 · Cited by 948 · see citing works
Introducing MASC: A Movie for the Assessment of Social Cognition
Dziobek, I., Fleck, S., Kalbe, E., Rogers, K., Hassenstab, J., Brand, M., Kessler, J., Woike, J. K., Wolf, O. T., & Convit, A. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0107-0 · Cited by 926 · see citing works
Mehrfachwahl-Wortschatz-Intelligenztest
Lehrl, S. (2005) · Cited by 735 · see citing works
Lüscher, C., & Slesinger, P. A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2834 · Cited by 617 · see citing works
Hare, T. A., Camerer, C. F., Knoepfle, D. T., O'Doherty, J. P., & Rangel, A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4089-09.2010 · Cited by 527 · see citing works
Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice
Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M., & Landgraf, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.003 · Cited by 511 · see citing works
Frye, C. A., Petralia, S. M., & Rhodes, M. E. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00392-0 · Cited by 438 · see citing works
Prejudice and truth about the effect of testosterone on human bargaining behaviour
Eisenegger, C., Naef, M., Snozzi, R., Heinrichs, M., & Fehr, E. (2009) · Nature · doi:10.1038/nature08711 · Cited by 430 · see citing works
Self-citationBos, P. A., Panksepp, J., Bluthé, R.-M., & Honk, J. V. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.01.002 · Cited by 429 · see citing works
MDMA enhances emotional empathy and prosocial behavior
Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst161 · Cited by 356 · see citing works
Self-citationSnead, O. C., & Gibson, K. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044047 · Cited by 311 · see citing works
Verbaler Lern- und Merkfähigkeitstest
Helmstaedter, C., Lendt, M., & Lux, S. (2001) · Cited by 282 · see citing works
Carter, L. P., Pardi, D., Gorsline, J., & Griffiths, R. R. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.012 · Cited by 281 · see citing works
Bedi, G., Hyman, D., & de Wit, H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.003 · Cited by 247 · see citing works
Van Cauter, E., Plat, L., Scharf, M. B., Leproult, R., Cespedes, S., L'Hermite-Balériaux, M., & Copinschi, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119587 · Cited by 234 · see citing works
Tomova, L., von Dawans, B., Heinrichs, M., Silani, G., & Lamm, C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.02.006 · Cited by 224 · see citing works
Self-citationGuennoun, R., Labombarda, F., Deniselle, M. C. G., Lière, P., Nicola, A. F. D., & Schumacher, M. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.09.001 · Cited by 223 · see citing works
Gamma-Hydroxybutyrate, a Normal Brain Metabolite
Bessman, S. P., & Fishbein, W. N. (1963) · Nature · doi:10.1038/2001207a0 · Cited by 216 · see citing works
Neurosteroids, stress and depression: Potential therapeutic opportunities
Zorumski, C. F., Paul, S. M., Izumi, Y., Covey, D. F., & Mennerick, S. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.005 · Cited by 196 · see citing works
Role of progesterone in nicotine addiction: Evidence from initiation to relapse.
Lynch, W. J., & Sofuoglu, M. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0021265 · Cited by 181 · see citing works
Schultheiss, O. C., Dargel, A., & Rohde, W. (2003) · Hormones and Behavior · doi:10.1016/s0018-506x(03)00003-5 · Cited by 171 · see citing works
Stimuli and consequences of dendritic release of oxytocin within the brain
Neumann, I. D. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351252 · Cited by 161 · see citing works
Next-Generation Treatments for Mental Disorders
Insel, T. R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004873 · Cited by 161 · see citing works
Impaired emotional empathy and related social network deficits in cocaine users
Preller, K. H., Hulka, L. M., Vonmoos, M., Jenni, D., Baumgartner, M. R., Seifritz, E., Dziobek, I., & Quednow, B. B. (2013) · Addiction Biology · doi:10.1111/adb.12070 · Cited by 155 · see citing works
Self-citationDifferential effects of MDMA and methylphenidate on social cognition
Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B. B., & Liechti, M. E. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114542454 · Cited by 155 · see citing works
Self-citationReputation for reciprocity engages the brain reward center
Phan, K. L., Sripada, C. S., Angstadt, M., & McCabe, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008137107 · Cited by 152 · see citing works
Social closeness increases salivary progesterone in humans
Brown, S. L., Fredrickson, B. L., Wirth, M. M., Poulin, M. J., Meier, E. A., Heaphy, E. D., Cohen, M. D., & Schultheiss, O. C. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.03.022 · Cited by 152 · see citing works
Wirth, M. M., & Schultheiss, O. C. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.08.003 · Cited by 139 · see citing works
Evidence for a G Protein‐Coupled γ‐Hydroxybutyric Acid Receptor
Snead, O. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751986.x · Cited by 124 · see citing works
γ‐Hydroxybutyrate (GHB) in Humans
Abanades, S., Farré, M., Segura, M., Pichini, S., Barral, D., Pacifici, R., Pellegrini, M., Fonseca, F., Langohr, K., & de la Torre, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.065 · Cited by 123 · see citing works
Elements of trust: Risk and perspective-taking
Evans, A. M., & Krueger, J. I. (2010) · Journal of Experimental Social Psychology · doi:10.1016/j.jesp.2010.08.007 · Cited by 121 · see citing works
Quednow, B. B., Kühn, K.-U., Hoenig, K., Maier, W., & Wagner, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300396 · Cited by 116 · see citing works
Self-citationGachet, M. S., Rhyn, P., Bosch, O. G., Quednow, B. B., & Gertsch, J. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.11.001 · Cited by 107 · see citing works
Self-citationUse, function, and subjective experiences of gamma-hydroxybutyrate (GHB)
Sumnall, H. R., Woolfall, K., Edwards, S. A., Cole, J. C., & Beynon, C. M. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.07.009 · Cited by 98 · see citing works
Keating, G. M. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0158-x · Cited by 93 · see citing works
Andresen, H., Aydin, B. E., Mueller, A., & Iwersen‐Bergmann, S. (2011) · Drug Testing and Analysis · doi:10.1002/dta.254 · Cited by 88 · see citing works
Kuypers, K. P. C., de la Torre, R., Farre, M., Yubero-Lahoz, S., Dziobek, I., Van den Bos, W., & Ramaekers, J. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100719 · Cited by 88 · see citing works
van IJzendoorn, M. H., Huffmeijer, R., Alink, L. R. A., Bakermans-Kranenburg, M. J., & Tops, M. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00258 · Cited by 83 · cited 1× · see citing works
“In several studies, oxytocin was hown to facilitate prosocial behavior including increased charty donations (van Ijzendoorn et al., 2011).”
The Endocrinology of Exclusion
Maner, J. K., Miller, S. L., Schmidt, N. B., & Eckel, L. A. (2010) · Psychological Science · doi:10.1177/0956797610362676 · Cited by 77 · see citing works
Barbaccia, M. L. (2004) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v16.i12.70 · Cited by 76 · see citing works
Meyer, M. R., Weber, A. A., & Maurer, H. H. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-4760-6 · Cited by 59 · see citing works
GABAB receptor-mediated increase of neurosteroids by γ-hydroxybutyric acid
Barbaccia, M. L., Colombo, G., Affricano, D., Carai, M. A. M., Vacca, G., Melis, S., Purdy, R. H., & Gessa, G. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00026-6 · Cited by 56 · see citing works
Nava, F. A., Premi, S., Manzato, E., Campagnola, W., Lucchini, A., & Gessa, G. L. (2007) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990701315046 · Cited by 51 · see citing works
Reconsidering GHB: orphan drug or new model antidepressant?
Bosch, O. G., Quednow, B. B., Seifritz, E., & Wetter, T. C. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111421975 · Cited by 49 · see citing works
Self-citationYonkers, K. A., Forray, A., Nich, C., Carroll, K. M., Hine, C. E., Merry, B. C., Shaw, H. A., Shaw, J., & Sofuoglu, M. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70333-5 · Cited by 48 · see citing works
Impaired social decision making in patients with major depressive disorder
Zhang, H., Sun, D., & Lee, T. M. C. (2012) · Brain and Behavior · doi:10.1002/brb3.62 · Cited by 39 · see citing works
Gamma Hydroxybutyrate: An Ethnographic Study of Recreational Use and Abuse
Lee, S. J., & Levounis, P. (2008) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2008.10400639 · Cited by 35 · see citing works
Uys, J. D. K., & Niesink, R. J. M. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500295725 · Cited by 34 · see citing works
γ-Hydroxybutyric Acid (GHB) Is Not an Agonist of Extrasynaptic GABAA Receptors
Connelly, W. M., Errington, A. C., & Crunelli, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079062 · Cited by 32 · see citing works
Nieuwenhuijzen, P. S. V., Long, L. E., Hunt, G. E., Arnold, J. C., & McGregor, I. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1986-5 · Cited by 31 · see citing works
Wendt, G., Kemmel, V., Patte‐Mensah, C., Uring‐Lambert, B., Eckert, A., Schmitt, M., & Mensah‐Nyagan, A. G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.067 · Cited by 28 · see citing works
Barbaccia, M. L., Carai, M. A. M., Colombo, G., Lobina, C., Purdy, R. H., & Gessa, G. L. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.026 · Cited by 19 · see citing works
Enhanced subgenual cingulate response to altruistic decisions in remitted major depressive disorder
Pulcu, E., Zahn, R., Moll, J., Trotter, P. D., Thomas, E. J., Juhász, G., Deakin, J. F. W., Anderson, I. M., Sahakian, B. J., & Elliott, R. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.04.010 · Cited by 18 · see citing works
[Utilization in psychiatry of gamma-OH].
Danon-Boileau, H., Lavitry, S., Lab, P., LEVY, E., Ruffiot, S., & Laborit, H. (1962) · PubMed · Cited by 14 · see citing works
CLINICAL APPLICATION OF 4‐HYDROXYBUTYRATE SODIUM AND 4‐BUTYROLACTONE IN NEUROPSYCHIATRIC PATIENTS
Tanaka, Z., Mukai, A., Takayanagi, Y., Muto, A., Mikami, Y., Miyakoshi, T., Araya, M., Ohdaira, T., & Aizawa, H. (1966) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1966.tb00055.x · Cited by 12 · see citing works
Systematic Assessment of Gamma Hydroxybutyrate (GHB) Effects During and After Acute Intoxication
Kim, S. Y., Barker, J. C., Anderson, I. B., Dyer, J. E., Earnest, G. E., & Blanc, P. D. (2008) · American Journal on Addictions · doi:10.1080/10550490802138988 · Cited by 7 · see citing works
Testosterone and behavior: Involvement of the hormone in psychotropic effects of baclofen
Амикишиева, А. В. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0065-3 · Cited by 6 · see citing works
Flagged first, then by citations
2 of the 61 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
A meta-analytic review of the correlation between peripheral oxytocin and cortisol concentrations
Brown, C. A., Cardoso, C., & Ellenbogen, M. A. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.11.001 · Cited by 129 · see citing works
Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects
Strajhar, P., Schmid, Y., Liakoni, E., Dolder, P. C., Rentsch, K., Kratschmar, D. V., Odermatt, A., & Liechti, M. E. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12374 · Cited by 129 · see citing works
Modulation of Social Cognition via Hallucinogens and “Entactogens”
Preller, K. H., & Vollenweider, F. X. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00881 · Cited by 71 · see citing works
Hassan, Z., Bosch, O. G., Singh, D., Narayanan, S., Kasinather, B. V., Seifritz, E., Kornhuber, J., Quednow, B. B., & Müller, C. P. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00152 · Cited by 63 · see citing works
Self-citationPharmacokinetics and pharmacodynamics of γ‐hydroxybutyrate in healthy subjects
Liechti, M. E., Quednow, B. B., Liakoni, E., Dornbierer, D., von Rotz, R., Gachet, M. S., Gertsch, J., Seifritz, E., & Bosch, O. G. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12863 · Cited by 56 · see citing works
Self-citationDufayet, L., Bargel, S., Bonnet, A., Boukerma, A. K., Chevallier, C., Evrard, M., Guillotin, S., Loeuillet, É., Paradis, C., Pouget, A.-M., et al. (2023) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2023.105435 · Cited by 46 · see citing works
Corkery, J., Loi, B., Claridge, H., Goodair, C., & Schifano, F. (2018) · Current Drug Metabolism · doi:10.2174/1389200218666171108163817 · Cited by 42 · see citing works
Hoffmann, S., Gerhardt, S., Mühle, C., Reinhard, I., Reichert, D., Bach, P., Boroumand-Jazi, R., Kuehner, C., Aguilera, A., Aslan, A., et al. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230027 · Cited by 38 · see citing works
Battista, A. P. D., Rhind, S. G., Churchill, N. W., Richards, D. W., Lawrence, D. W., & Hutchison, M. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-54923-3 · Cited by 33 · see citing works
Cognitive effects of labeled addictolytic medications
Pujol, C., Paasche, C., Laprévote, V., Trojak, B., Vidailhet, P., Bacon, É., & Lalanne, L. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.008 · Cited by 28 · see citing works
The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans
Bosch, O. G., & Seifritz, E. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.02.002 · Cited by 25 · see citing works
Self-citationWunderli, M. D., Vonmoos, M., Treichler, L., Zeller, C., Dziobek, I., Kræmer, T., Baumgartner, M. R., Seifritz, E., & Quednow, B. B. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx098 · Cited by 22 · see citing works
Self-citationNeural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans
Bosch, O. G., Havranek, M. M., Baumberger, A., Preller, K. H., von Rotz, R., Herdener, M., Kraehenmann, R., Staempfli, P., Scheidegger, M., Klucken, T., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.02.006 · Cited by 22 · see citing works
Self-citationBosch, O., Esposito, F., Havranek, M. M., Dornbierer, D. A., von Rotz, R., Staempfli, P., Quednow, B., & Seifritz, E. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.110 · Cited by 22 · see citing works
Self-citationEffect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator
Liakoni, E., Dempsey, D. A., Meyers, M. J., Murphy, N. G., Fiorentino, D. D., Havel, C. M., HALLER, C. A., & Benowitz, N. L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5025-2 · Cited by 18 · see citing works
von Rotz, R., Kometer, M., Dornbierer, D., Gertsch, J., Gachet, M. S., Vollenweider, F. X., Seifritz, E., Bosch, O. G., & Quednow, B. B. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4603-z · Cited by 18 · see citing works
Self-citationToxicological Characterization of GHB as a Performance-Enhancing Drug
Giorgetti, A., Busardò, F. P., & Giorgetti, R. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.846983 · Cited by 17 · see citing works
Küting, T., Schneider, B., Heidbreder, A., Krämer, M., Jarsiah, P., Madea, B., & Heß, C. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3097 · Cited by 16 · see citing works
Dornbierer, D., Boxler, M. I., Voegel, C. D., Stucky, B., Steuer, A. E., Binz, T. M., Baumgartner, M. R., Baur, D. M., Quednow, B. B., Kræmer, T., et al. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz047 · Cited by 15 · see citing works
Self-citationBeurmanjer, H., Asperslag, E. M., Oliemeulen, L., Goudriaan, A. E., de Jong, C. A. J., Schellekens, A., & Dijkstra, B. A. G. (2019) · European Addiction Research · doi:10.1159/000500807 · Cited by 14 · see citing works
Bosch, O. G., Esposito, F., Dornbierer, D., Havranek, M. M., von Rotz, R., Kometer, M., Stämpfli, P., Quednow, B. B., & Seifritz, E. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.03.011 · Cited by 13 · see citing works
Self-citationvan Amsterdam, J., Brunt, T. M., Pereira, F. R., Crunelle, C. L., & van den Brink, W. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210610094352 · Cited by 13 · see citing works
Steuer, A. E., Sutter, L., Steuer, C., & Kræmer, T. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3430 · Cited by 11 · see citing works
Case report: Another death associated to γ-hydroxybutyric acid intoxication
Küting, T., Krämer, M., Bicker, W., Madea, B., & Heß, C. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.03.028 · Cited by 11 · see citing works
Bosch, O. G., Esposito, F., Dornbierer, D., von Rotz, R., Krähenmann, R., Stämpfli, P., Quednow, B. B., & Seifritz, E. (2018) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2679 · Cited by 10 · see citing works
Self-citationChen, Y., Xu, M., & Wang, X. (2020) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2020.00800 · Cited by 9 · see citing works
Dornbierer, D., Kometer, M., von Rotz, R., Studerus, E., Gertsch, J., Gachet, M. S., Vollenweider, F. X., Seifritz, E., Bosch, O. G., & Quednow, B. B. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.02.004 · Cited by 8 · see citing works
Self-citationDufayet, L., Bargel, S., Bonnet, A., Boukerma, A. K., Chevallier, C., Evrard, M., Guillotin, S., Loeuillet, É., Paradis, C., Pouget, A.-M., et al. (2022) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2022.09.004 · Cited by 5 · see citing works
Gachet, M. S., & Gertsch, J. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.11.013 · Cited by 5 · see citing works
Self-citationCamuto, C., Arfè, R., Tirri, M., de la Torre, X., Mazzarino, M., Marti, M., De‐Giorgio, F., & Botrè, F. (2021) · Emerging Trends in Drugs Addictions and Health · doi:10.1016/j.etdah.2021.100028 · Cited by 4 · see citing works
Bavato, F. (2024) · The Receptors · doi:10.1007/978-3-031-67148-7_13 · Cited by 3 · see citing works
Küting, T., Beier, N., Krämer, M., & Madea, B. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa096 · Cited by 2 · see citing works
Oral sodium oxybate does not alter plasma kisspeptin levels in healthy male volunteers
Bavato, F., Schnider, L. K., Dornbierer, D., & Seifritz, E. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231185097 · Cited by 2 · see citing works
Self-citationGiorgetti, A., Giorgetti, R., & Basile, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_119 · Cited by 1 · see citing works
Pardi, D. (2019) · Data Archiving and Networked Services (DANS)
Giorgetti, A., Giorgetti, R., & Basile, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_119-1
Yates, J. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90578-7.00014-1
Goulart, J. Q., Matias, C. L., Prado, P. C. D., Weber, C., & Pinto, A. T. (2023) · Vigilância Sanitária em Debate · doi:10.22239/2317-269x.02134
Revealing GABA Induced Depression: Dual Validation of Animal Experiments and Clinical Data
Chen, S. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.ld24093
Low salivary pH reflects high dental anxiety: evidence from a preliminary cross-sectional study
Taş, A., & Agbulut, N. (2025) · Odontology · doi:10.1007/s10266-025-01238-7
Colin, L., Iglói, K., Montagrin, A., Kumar, S., Hofmeister, J., Gschwind, M., Schwartz, S., & Virginie Sterpenich, A. (2026) · Journal of Sleep Research · doi:10.1111/jsr.70386
Smith, S., Mohammad, H., Lee, L.-H. N., Dennett, L., Smith, S., Burback, L., Winkler, O., Greenshaw, A., Jetly, R., Kennedy, S., et al. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07110-y
- Authors
- Bosch, O. G., Eisenegger, C., Gertsch, J., von Rotz, R., Dornbierer, D., Gachet, M. S., Heinrichs, M., Wetter, T. C., Seifritz, E., & Quednow, B. B.
- Affiliations
- University of Zurich (CH)
- University of Vienna (AT)
- University of Bern (CH)
- University of Freiburg (DE)
- University of Regensburg (DE)
- Corresponding author
- Bosch, Oliver G.
- ORCID
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 62
- Pages
- 1-10
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2170730440
- Cited by
- 42
- References
- 61
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 3 · 2015: 2
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.zora.uzh.ch
- Licence
- Locations
- Psychoneuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- BORIS (University Library Bern) (submittedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Keywords
- gamma-hydroxybutyric acid, GABA-B receptor agonist, mood improvement, prosocial behavior, oxytocin, testosterone, progesterone, social cognition, empathy, theory of mind, emotion recognition, social value orientation, reciprocity, euphoria, neuroendocrine effects
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Affect, Aldosterone, Brain, Dehydroepiandrosterone, Emotions, Humans, Hydrocortisone, Hydroxybutyrates, Male, Oxytocin, Progesterone, Social Behavior, Testosterone, Cross-Over Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review